MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/14740338.2024.2386371

Медицинская библиотека · Expert opinion on drug safety · 2024

Disproportionality analysis of data from VigiBase and other global product safety databases on toxicity of iron chelating agents.

Arda Burcu Eda, Sipahi Hande

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Iron chelators; deferasirox, deferiprone, and deferoxamine; used to treat iron toxicities due to excessive ingestions or blood transfusions, may cause serious adverse reactions.

RESEARCH DESIGN AND

METHODS

This study investigates pharmacovigilance data to uncover unknown safety information. Disproportionality analysis was conducted using VigiBase, the WHO global database of individual case safety reports, to known safety profile of products and the FDA Adverse Event Reporting System, reviewing over 117.000 iron chelator cases between 2010 and 2020.

RESULTS

Commonly reported adverse events for iron chelators are general disorders and administration site conditions and GI-related disorders. Reporting Odds Ratio was calculated for iron chelator associations to headache (common), blurred vision (rare) and sepsis (serious). Strong association between deferoxamine and blurred vision (ROR: 2.47 in VigiBase and 3.04 in FAERS), deferiprone and sepsis (ROR; 5.95 in VigiBase and 1.24 in FAERS) were identified. However, results showed some inconsistent associations, such as headache and deferiprone, blurred vision and deferasirox association as per FAERS data; sepsis and deferasirox and deferoxamine association as per VigiBase data. Forty-five new potential signals with different associative values were suggested.

CONCLUSION

The study identified strong associations between specific iron chelators and adverse events, though some inconsistencies were observed in the data. These findings, including the 45 new potential signals, suggest areas for further review and validation with additional data.

Для цитирования: Arda Burcu Eda, Sipahi Hande. Disproportionality analysis of data from VigiBase and other global product safety databases on toxicity of iron chelating agents.. Expert opinion on drug safety. 2024. DOI: 10.1080/14740338.2024.2386371.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.